![Peter H. Calcott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Peter H. Calcott.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Protein Design Labs, Inc.
![]() Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
23
| Extinct | Pharmaceuticals: Major | 23 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Peter H. Calcott a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
PDL BIOPHARMA, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chairman Chief Tech/Sci/R&D Officer Human Resources Officer Sales & Marketing Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chairman General Counsel Director/Board Member Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal General Counsel General Counsel Public Communications Contact | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Compliance Officer Chairman General Counsel | |
Genetics Institute LLC
![]() Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
EOS Biotechnology, Inc.
![]() EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Sandoz Ltd.
![]() Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Stellular Bio, Inc.
![]() Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Corixa Corp.
![]() Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Founder Director/Board Member | |
CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chairman | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
LADRX CORPORATION | Biotechnology | Corporate Officer/Principal Chairman | |
The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal Doctorate Degree | |
SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Stanford University | College/University | Graduate Degree Undergraduate Degree | |
The University of Chicago | College/University | Undergraduate Degree Doctorate Degree | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing | |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Chairman | |
ORTHOsoft ULC
![]() ORTHOsoft ULC Packaged SoftwareTechnology Services Part of Zimmer Biomet Holdings, Inc., ORTHOsoft ULC is a Canadian medical software development company. The company is based in Montréal, Canada. Louis-Philippe Amiot has been the CEO of the company since 1995. ORTHOsoft ULC was acquired by Zimmer Biomet Holdings, Inc. on October 16, 2007 for $46.36 million. | Packaged Software | Director/Board Member | |
Sandoz, Inc.
![]() Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
IMUNON, INC. | Biotechnology | Chairman | |
Boehringer Mannheim Diagnostics Corp.
![]() Boehringer Mannheim Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX. | Medical Specialties | Chief Executive Officer | |
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Mipharm SpA
![]() Mipharm SpA Pharmaceuticals: MajorHealth Technology Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Chairman | |
Sandoz Pharmaceuticals AG
![]() Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Biotechnology | Chief Executive Officer | |
SINTX TECHNOLOGIES, INC. | Medical Specialties | Chairman | |
Aeon Scientific AG
![]() Aeon Scientific AG Medical SpecialtiesHealth Technology Aeon Scientific AG engages in the development of medical devices for cardiac interventions. Its product supports electro physiologists during ablation procedures, such as for the treatment of Atrial Fibrillation. The technology is a platform with additional potential in other medical applications such as for gastroenterology, neurosurgery and targeted drug delivery in general. The company was founded by Dominik J. Bell in October 2010 and is headquartered in Zurich, Switzerland. | Medical Specialties | Chairman | |
University of California, Berkeley | College/University | Doctorate Degree | |
JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Corridor Pharmaceuticals, Inc.
![]() Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Pharmaceuticals: Major | Director/Board Member | |
The Wistar Institute
![]() The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | Director/Board Member | |
Rose-Hulman Institute of Technology, Inc. | College/University | Undergraduate Degree | |
Indiana University | College/University | Masters Business Admin | |
University of Akron
![]() University of Akron Other Consumer ServicesConsumer Services University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH. | College/University | Graduate Degree | |
University of Oklahoma | College/University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 39 |
Suiza | 6 |
Alemania | 4 |
Canadá | 3 |
Reino Unido | 2 |
Sectorial
Health Technology | 36 |
Consumer Services | 12 |
Commercial Services | 3 |
Technology Services | 2 |
Non-Energy Minerals | 2 |
Operativa
Director/Board Member | 89 |
Corporate Officer/Principal | 61 |
Chief Tech/Sci/R&D Officer | 28 |
Independent Dir/Board Member | 28 |
Chairman | 26 |
Las relaciones más conectadas
Insiders | |
---|---|
Mark McDade | 35 |
Max E. Link | 28 |
Leonard Patrick Gage | 26 |
Karen Dawes | 22 |
Samuel Broder | 18 |
Jaisim Shah | 17 |
Barbara Finck | 15 |
George T. Jue | 15 |
George M. Gould | 13 |
Steven E. Benner | 13 |
Laurie C. Torres | 11 |
Richard Murray | 10 |
Robert J. Stagg | 9 |
Sergio Garcia-Rodriguez | 8 |
Cynthia Shumate | 7 |
- Bolsa de valores
- Insiders
- Peter H. Calcott
- Conexiones Empresas